News Daily News Oral GLP-1s Provide Benefit in HF Patients: SOUL Subanalysis L.A. McKeown February 06, 2026
News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF Todd Neale December 05, 2025
News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF Todd Neale November 14, 2025
News Daily News HYPERION: Sotatercept Helps in PAH Even When Started Earlier in the Disease Todd Neale October 02, 2025
News Conference News HFSA 2025 Lowering Novel Biomarker, GDF-15, Raises HF Event Rate: GARDEN-TIMI 74 Yael L. Maxwell September 30, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2025 Michael O'Riordan September 30, 2025
News Conference News ESC 2025 ESC Guidelines Update Clarifies Pregnancy Risks and Choices in Women With CVD L.A. McKeown September 09, 2025
News Conference News ESC 2025 Starting SGLT2 Inhibitors in the Hospital for Acute HF Gains Support Todd Neale August 30, 2025
News Conference News ESC 2025 Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF Michael O'Riordan August 29, 2025
News Conference News ESC 2025 Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias Todd Neale August 29, 2025
News Daily News Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks Michael O'Riordan August 01, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2025 Michael O'Riordan June 30, 2025
News Conference News ESC Heart Failure 2025 Finerenone May Cut Early Readmissions in HF Patients Todd Neale May 21, 2025
News Daily News Benefits of SGLT2 Inhibitors for HF Affirmed in Large, Real-world Study Todd Neale May 09, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2025 Caitlin E. Cox April 01, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025